InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Sanna Bastiano, Vice-Président Exécutif, Thérapies Cellulaires et Génétiques. Officer active across 3 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 31 disclosures have been recorded. Split: 0 buy · 15 sells. Total volume traded: €3.3m. Activity tracked since 30 April 2021. The latest transaction was disclosed on 1 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sanna Bastiano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
5,900 shares0Common StockSEC:0001209191-23-033960:0
422 shares@ US$350.031.5% of flowCommon StockSEC:0001209191-23-028243:0
1,411 shares@ US$350.325.2% of flowCommon StockSEC:0001209191-23-027374:0
874 shares@ US$325.703.0% of flowCommon StockSEC:0001209191-23-024312:0
211 shares@ US$314.220.7% of flowCommon StockSEC:0001209191-23-023588:0
1,466 shares@ US$313.744.8% of flowCommon StockSEC:0001209191-23-022695:0
2,482 shares@ US$300.548.1% of flowCommon StockSEC:0001209191-23-020043:0
3,970 shares@ US$289.1212.4% of flowCommon StockSEC:0001209191-23-013757:0
3,750 shares@ US$292.8511.8% of flowCommon StockSEC:0001209191-23-011701:0
1,902 shares@ US$300.296.1% of flowCommon StockSEC:0001209191-23-010055:0
902 shares@ US$294.332.8% of flowCommon StockSEC:0001209191-23-009232:0
9,092 shares0Common StockSEC:0001209191-23-006980:0
106 shares@ US$325.000.4% of flowCommon StockSEC:0001209191-23-006215:0
768 shares@ US$312.842.8% of flowCommon StockSEC:0000899243-22-034883:0
1,503 shares@ US$300.025.2% of flowCommon StockSEC:0000899243-22-033880:0
766 shares@ US$276.622.4% of flowCommon StockSEC:0000899243-22-027571:0
7 shares@ US$250.560.0000% mcap0.1% of flowCommon StockSEC:0000899243-22-018605:0
36 shares@ US$275.090.0000% mcap0.3% of flowCommon StockSEC:0000899243-22-017086:0
20 shares@ US$255.470.0000% mcap0.2% of flowCommon StockSEC:0000899243-22-016641:0
766 shares@ US$276.170.0002% mcap7.1% of flowCommon StockSEC:0000899243-22-016316:0
204 shares@ US$275.710.0000% mcap1.8% of flowCommon StockSEC:0000899243-22-014360:0
305 shares@ US$267.100.0001% mcap2.6% of flowCommon StockSEC:0000899243-22-014120:0
1,344 shares@ US$263.090.0003% mcap11.2% of flowCommon StockSEC:0000899243-22-013705:0
2,122 shares@ US$250.060.0004% mcap16.9% of flowCommon StockSEC:0000899243-22-011701:0
3,439 shares@ US$232.510.0006% mcap24.6% of flowCommon StockSEC:0000899243-22-007215:0
25 of 31 declarations
About Sanna Bastiano
Sanna Bastiano is Vice-Président Exécutif, Thérapies Cellulaires et Génétiques, and Director at Adicet Bio, Inc. Across 31 filings, the 31 filings available cover the period from 2021-05-05 to 2023-06-02, with 0 EUR of buys and 3263032 EUR of sells in the sampled recent filings.
